Showing 41,401 - 41,420 results of 64,804 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.29s Refine Results
  1. 41401

    Image_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.JPEG by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  2. 41402

    Data_Sheet_12_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  3. 41403

    Table_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  4. 41404

    Data_Sheet_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  5. 41405

    Data_Sheet_15_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  6. 41406

    Data_Sheet_5_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  7. 41407

    Data_Sheet_1_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  8. 41408

    Data_Sheet_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  9. 41409

    Data_Sheet_7_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  10. 41410

    Data_Sheet_8_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  11. 41411

    Data_Sheet_11_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  12. 41412

    Data_Sheet_9_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  13. 41413

    Data_Sheet_6_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  14. 41414

    Table_4_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  15. 41415

    Table_2_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  16. 41416

    Data_Sheet_13_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.PDF by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  17. 41417

    Table_3_Global burden of multiple sclerosis and its attributable risk factors, 1990–2019.DOC by Saeid Safiri (3713035)

    Published 2024
    “…In 2019, females exhibited a higher global point prevalence and a greater total number of prevalent MS cases than males across all age groups. …”
  18. 41418

    Table 1_The kinetic behavior of matrine in pig intestinal lumen after oral administration and its physiologically based pharmacokinetic modeling.docx by Bo Yang (104813)

    Published 2025
    “…The concentration-time data were analysed by non-compartmental method. Subsequently, a four-compartment PBPK model was developed and validated.…”
  19. 41419

    Image_4_Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway.JPEG by Aijuan Yan (4578646)

    Published 2021
    “…</p><p>Conclusion: This study suggests that systemic inflammation, by exacerbating preexisting neuroinflammation and facilitating NR2B subunit activity, may play a crucial role in the development of LID. The administration of Clo-lipo restores the effects of LPS and decreases the susceptibility to LID in 6-OHDA lesioned rats.…”
  20. 41420

    Image_1_Systemic Inflammation Increases the Susceptibility to Levodopa-Induced Dyskinesia in 6-OHDA Lesioned Rats by Targeting the NR2B-Medicated PKC/MEK/ERK Pathway.JPEG by Aijuan Yan (4578646)

    Published 2021
    “…</p><p>Conclusion: This study suggests that systemic inflammation, by exacerbating preexisting neuroinflammation and facilitating NR2B subunit activity, may play a crucial role in the development of LID. The administration of Clo-lipo restores the effects of LPS and decreases the susceptibility to LID in 6-OHDA lesioned rats.…”